As the United States prepares for future pandemics and emerging biological threats, Texas is rapidly becoming one of the country’s most important centers for infectious disease research and biodefense innovation.
A growing network of research institutions across the state, including Texas Biomedical Research Institute (Texas Biomed) in San Antonio, the University of Texas Medical Branch (UTMB) in Galveston, and Southwest Research Institute (SwRI), is helping expand America’s ability to study dangerous pathogens, develop medical countermeasures, and strengthen national preparedness.
At the center of that effort is Texas Biomed, home to the nation’s only privately owned Biosafety Level 4 (BSL-4) laboratory.
Why BSL-4 research facilities matter
BSL-4 laboratories are among the most secure and specialized scientific facilities in the world. They are designed to safely study dangerous pathogens that can cause severe or fatal disease in humans, including viruses such as Ebola and Marburg.
These facilities play a critical role in:
- Pandemic preparedness
- Vaccine and therapeutic development
- Emerging infectious disease research
- Biodefense and national security efforts
- Rapid response to global outbreaks
The COVID-19 pandemic underscored the importance of expanding high-containment laboratory capacity in the United States. Since then, demand for advanced infectious disease research infrastructure has continued to grow across both public and private sectors.
Texas Biomed’s expanding role in national preparedness
Texas Biomed has operated a BSL-4 facility in San Antonio since 1999, giving the Institute decades of experience supporting high-containment infectious disease research.
The Institute is now expanding its capacity through the development of a new research center designed to further support work on pandemics, biological threats, and emerging infectious diseases. The expansion reflects rising national demand for specialized facilities capable of safely conducting this type of research.
As federal agencies, academic partners, and biotechnology companies increasingly seek access to high-containment research environments, institutions like Texas Biomed are becoming central to the national biodefense infrastructure.
Expert perspective on Texas Biomed’s national role
Experts in biodefense and public health policy emphasize the importance of institutions like Texas Biomed in responding to both natural and intentional biological threats.
Dr. Gerry Parker, DVM, Ph.D., Head of Faculty at Texas A&M University College of Veterinary Medicine & Biomedical Sciences and former head of the White House Office of Pandemic Preparedness and Response Policy, highlighted the Institute’s unique role:
“Every time there’s a major outbreak, we have to go to the laboratory. Texas Biomedical Research Institute not only brings forth the scientific expertise but is also the only private sector non-profit organization in the United States that has a laboratory capability to help the nation confront some of the biggest threats that we face from a biodefense perspective, in addition to the emerging and reemerging natural diseases.”
This perspective reflects the growing recognition of Texas Biomed as a critical national asset in both pandemic preparedness and biodefense readiness.
Texas Is Building a Biodefense Corridor
Texas’ influence in infectious disease research extends beyond San Antonio.
UTMB Galveston is a nationally recognized leader in emerging infectious disease research and high-containment science, while Southwest Research Institute contributes advanced engineering, applied science, and defense-related research capabilities.
Together, these institutions form a growing Texas biodefense ecosystem focused on:
- Infectious disease innovation
- Medical countermeasure development
- Public-private research partnerships
- Biosecurity and biodefense initiatives
- Workforce development in bioscience and biotechnology
This concentration of infrastructure and expertise positions Texas as an increasingly important hub for national health security.
The growing global demand for infectious disease research
The global market for infectious disease research and development continues to expand as governments and industry invest in preparedness, diagnostics, vaccines, and antiviral therapies.
This growth is increasing demand for institutions capable of conducting high-containment research safely and at scale — particularly BSL-4 laboratories with established expertise and regulatory experience.
Texas Biomed’s expansion reflects this broader shift toward strengthening scientific capacity for global health threats.
Preparing for the next biological threat
Future biological threats, whether emerging infectious diseases or deliberate biological events, will require faster collaboration, stronger infrastructure, and advanced research capabilities.
Institutions like Texas Biomed are helping meet that need by expanding the United States’ ability to study high-consequence pathogens and accelerate the development of medical countermeasures.
As investment in biodefense and pandemic preparedness continues to grow, Texas is positioning itself as one of the nation’s leading centers for this critical work, with San Antonio emerging as a key node in global health security.